LEADXPRO TO WORK WITH CREOPTIX WAVE TECHNOLOGY FOR THEIR MEMBRANE PROTEIN DRUG DISCOVERY PROJECTS

Creoptix and leadXpro AG announce the selection of the Creoptix WAVE technology by leadXpro to strengthen its capabilities for drug discovery aimed at identifying and optimizing drug candidates directed against challenging membrane protein drug targets. [more]

Last modified onWednesday, 15 November 2017 10:27